Pathogenesis, assessment, and management of bone loss in axial spondyloarthritis

被引:5
作者
Nakamura, Akihiro [1 ,2 ,3 ,4 ]
Towheed, Tanveer [1 ,2 ,3 ,5 ]
机构
[1] Queens Univ, Dept Med, Div Rheumatol, Kingston, ON, Canada
[2] Queens Univ, Translat Inst Med, Sch Med, Kingston, ON, Canada
[3] Kingston Hlth Sci Ctr, Kingston, ON, Canada
[4] Queens Univ, Translat Inst Med, Sch Med, Dept Med,Div Rheumatol, 94 Stuart St, Kingston, ON K7L 3N6, Canada
[5] Queens Univ, Dept Med, Div Rheumatol, 94 Stuart St, Kingston, ON K7L 3N6, Canada
关键词
Axial Spondyloarthritis (axSpA); DXA (dual x-ray absorptiometry); Interleukin-17; Macrophage migration inhibitory factor (MIF); Mechanical stress; Microbiome; Osteoblast; Osteoclast; Osteoporosis; RANKL (Receptor activator of nuclear factor; kappa-B ligand); Trabecular Bone Score; Tumor Necrosis Factor; Vertebral Fracture; MESENCHYMAL STEM-CELLS; ANKYLOSING-SPONDYLITIS; RHEUMATOID-ARTHRITIS; MINERAL DENSITY; NECROSIS-FACTOR; OSTEOCLAST DIFFERENTIATION; QUANTITATIVE ULTRASOUND; VERTEBRAL FRACTURES; SPINAL PROGRESSION; RECEPTOR ACTIVATOR;
D O I
10.1016/j.semarthrit.2023.152345
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Axial spondyloarthritis (axSpA) presents a complex scenario where both new bone formation in entheseal tissues and significant trabecular bone loss coexist, emphasizing the intricate nature of bone dynamics in this context. Methods: A search of the literature was conducted to compose a narrative review exploring the pathogenesis, possible assessment methods, and potential management options for axSpA. Results: While chronic systemic and local inflammation contribute to bone loss, the mechanisms behind axSpAassociated bone loss exhibit distinct characteristics influenced by factors like mechanical stress and the gut microbiome. These factors directly or indirectly stimulate osteoclast differentiation and activation through the RANK-RANKL axis, while simultaneously impeding osteoblast differentiation via negative regulation of bone anabolic pathways, including the Wnt signaling pathway. This disruption in the balance between bone-resorbing osteoclasts and bone-forming osteoblasts contributes to overall bone loss in axSpA. Early evaluation at diagnosis is prudent for detecting bone changes. While traditional dual x-ray absorptiometry (DXA) has limitations due to potential overestimation from spinal new bone formation, alternative methods like trabecular bone score (TBS), quantitative CT (QCT), and quantitative ultrasound (QUS) show promise. However, their integration into routine clinical practice remains limited. In addition to approved anti-inflammatory drugs, lifestyle adjustments like regular exercise play a key role in preserving bone health. Tailoring interventions based on individual risk profiles holds potential for mitigating bone loss progression. Conclusion: Recognizing the pivotal role of bone loss in axSpA underscores the importance of integrating regular assessments and effective management strategies into clinical practice. Given the multifaceted contributors to bone loss in axSpA, a multidisciplinary approach is essential.
引用
收藏
页数:13
相关论文
共 148 条
[1]   JAK inhibition increases bone mass in steady-state conditions and ameliorates pathological bone loss by stimulating osteoblast function [J].
Adam, Susanne ;
Simon, Nils ;
Steffen, Ulrike ;
Andes, Fabian T. ;
Scholtysek, Carina ;
Mueller, Dorothea I. H. ;
Weidner, Daniela ;
Andreev, Darja ;
Kleyer, Arnd ;
Culemann, Stephan ;
Hahn, Madelaine ;
Schett, Georg ;
Kroenke, Gerhard ;
Frey, Silke ;
Hueber, Axel J. .
SCIENCE TRANSLATIONAL MEDICINE, 2020, 12 (530)
[2]   Interleukin-17A upregulates receptor activator of NF-κB on osteoclast precursors [J].
Adamopoulos, Iannis E. ;
Chao, Cheng-chi ;
Geissler, Richard ;
Laface, Drake ;
Blumenschein, Wendy ;
Iwakura, Yoichiro ;
McClanahan, Terrill ;
Bowman, Edward P. .
ARTHRITIS RESEARCH & THERAPY, 2010, 12 (01)
[3]   Osteoporosis in Inflammatory Bowel Disease [J].
Ali, Tauseef ;
Lam, David ;
Bronze, Michael S. ;
Humphrey, Mary Beth .
AMERICAN JOURNAL OF MEDICINE, 2009, 122 (07) :599-604
[4]   Increase in bone mineral density of patients with spondyloarthropathy treated with anti-tumour necrosis factor α [J].
Allali, F ;
Breban, M ;
Porcher, R ;
Maillefert, JF ;
Dougados, M ;
Roux, C .
ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (04) :347-349
[5]   Osteocyte necrosis triggers osteoclast-mediated bone loss through macrophage-inducible C-type lectin [J].
Andreev, Darja ;
Liu, Mengdan ;
Weidner, Daniela ;
Kachler, Katerina ;
Faas, Maria ;
Gruneboom, Anika ;
Schlotzer-Schrehardt, Ursula ;
Munoz, Luis E. ;
Steffen, Ulrike ;
Grotsch, Bettina ;
Killy, Barbara ;
Kronke, Gerhard ;
Luebke, Andreas M. ;
Niemeier, Andreas ;
Wehrhan, Falk ;
Lang, Roland ;
Schett, Georg ;
Bozec, Aline .
JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (09) :4811-4830
[6]   Bone mineral density improves during 2 years of treatment with bisphosphonates in patients with ankylosing spondylitis [J].
Arends, Suzanne ;
Wink, Freke ;
Veneberg, Joyce ;
Bos, Reinhard ;
van Roon, Eric ;
van der Veer, Eveline ;
Maas, Fiona ;
Spoorenberg, Anneke .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (02) :644-651
[7]   Autoamplification of NFATc1 expression determines its essential role in bone homeostasis [J].
Asagiri, M ;
Sato, K ;
Usami, T ;
Ochi, S ;
Nishina, H ;
Yoshida, H ;
Morita, I ;
Wagner, EF ;
Mak, TW ;
Serfling, E ;
Takayanagi, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (09) :1261-1269
[8]   Presence of HLA-B27 is associated with changes of serum levels of mediators of the Wnt and hedgehog pathway [J].
Aschermann, Sarah ;
Englbrecht, Matthias ;
Bergua, Antonio ;
Spriewald, Bernd M. ;
Said-Nahal, Rhula ;
Breban, Maxime ;
Schett, Georg ;
Rech, Juergen .
JOINT BONE SPINE, 2016, 83 (01) :43-46
[9]   The impact of anti-TNF treatment on Wnt signaling, noggin, and cytokine levels in axial spondyloarthritis [J].
Atas, Nuh ;
Cakir, Bagdagul ;
Bakir, Fatih ;
Ucar, Murat ;
Satis, Hasan ;
Guz, Gizem Tugce ;
Demirel, Kubra Durmus ;
Babaoglu, Hakan ;
Salman, Reyhan Bilici ;
Guler, Aslihan Avanoglu ;
Karadeniz, Hazan ;
Haznedarogu, Seminur ;
Goker, Berna ;
Ozturk, Mehmet Akif ;
Tufan, Abdurrahman .
CLINICAL RHEUMATOLOGY, 2022, 41 (05) :1381-1389
[10]   Interleukin-17A Stimulates Granulocyte-Macrophage Colony-Stimulating Factor Release by Murine Osteoblasts in the Presence of 1,25-Dihydroxyvitamin D3 and Inhibits Murine Osteoclast Development In Vitro [J].
Balani, Deepak ;
Aeberli, Daniel ;
Hofstetter, Willy ;
Seitz, Michael .
ARTHRITIS AND RHEUMATISM, 2013, 65 (02) :436-446